Julie Brown

Chief Financial Officer, GSK

About

Julie Brown is the Chief Financial Officer of GSK, the pharmaceutical and vaccines company, and a member of its Board and Executive Committee. She joined GSK in April 2023 as CFO Designate and joined the Board as CFO on 1 May 2023, succeeding Iain Mackay. She was the first woman to hold the CFO post at GSK, and she took the role while Emma Walmsley was chief executive.

Brown qualified with KPMG International and is a Fellow of the Institute of Chartered Accountants and of the Institute of Tax. She held finance, commercial and strategy roles at AstraZeneca, including a period as interim Group CFO; Aradhana Sarin now holds the AstraZeneca CFO post. She was Group CFO of Smith & Nephew from 2013 to 2017 and then Chief Operating Officer and Chief Financial Officer of Burberry Group from 2017 to 2023. She was also a Non-Executive Director and Audit Chair of Roche from 2016 to 2022.

Whoo compiled this page from public sources: GSK leadership page, GSK press release, September 2022, BioPharma Dive. It is not affiliated with or endorsed by Julie Brown. Are you Julie Brown? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Chief Financial Officer — GSK


May 2023 – Present

  • Joined GSK in April 2023 as CFO Designate

  • Member of the Board and the Executive Committee
  • Chief Operating Officer and Chief Financial Officer — Burberry Group plc


    2017 – 2023

    Non-Executive Director and Audit Chair — Roche Holding AG


    2016 – 2022

    Group Chief Financial Officer — Smith & Nephew


    2013 – 2017

    Finance, commercial and strategy roles — AstraZeneca

  • Included a period as interim Group CFO

Education

Education


Not published in sources

Projects